Our multidisciplinary team specializing in the treatment of adrenal tumors consists of

  • Oncologists (Stephen Leong, Christopher Lieu)
  • Endocrine Surgeons (Christopher Raeburn, Robert McIntyre, Maria Albuja-Cruz and Richard Schulick)
  • Endocrinologists (Margaret Wierman, Katja Kiseljak-Vassiliades, Lauren Fishbein)
  • Radiation Oncology
  • Medical Genetics

The University of Colorado multidisciplinary Adrenal Cancer Program established in 2013 offers a comprehensive treatment approach, and patients benefit from the expertise of a team of physicians.

Our multidisciplinary tumor board meets regularly to discuss the best treatment options for each patient.

Patients with adrenal cancer are seen within one week of referral and we offer same-day outpatient evaluation in a joint Endocrine, Surgery and Oncology clinic.

can-uch-nci-designationCurrently the primary treatment for adrenal tumor is surgical removal of the tumor within the adrenal gland, as well as all surrounding structures that may have been invaded by the tumor. At University of Colorado our Endocrine Surgery team has advanced expertise in adrenal tumor surgery. In unresectable or recurrent tumors surgery, medical therapy, chemotherapy and radiation are potential options.

We are actively pursuing research in the area of adrenal cancer and adrenal and extra-adrenal tumors called pheochromocytoma and paraganglioma respectively, as there is a need for better targeted medical treatments. Our research is focused on uncovering new genes and molecular pathways in these tumors that could be targeted in patients with adrenal cancer.

Advanced treatment and research

As the regional leader in cancer research, treatment and support, at University of Colorado you will get specialized multidisciplinary care not available anywhere else in Colorado.

  • Experts in cancer diagnosis and staging, which are the first steps for getting proper cancer care
  • Expert endocrine surgeons specializing in adrenal tumor surgery
  • Treatment strategies and monitoring based on the latest guidelines, and potential for enrolment into clinical trials when available

Second opinions

Get Second Opinions and Remote Second Opinions

The University of Colorado Cancer Center is a nationally recognized center for second opinions regarding all aspects cancer.

To schedule your second opinion consultation, call 303-724-4156.

What to bring to your second opinion appointment

Our second opinions are based on our review of all available information, including comprehensively re-reviewing all scans and tests.

Please bring all medical records dating back to your diagnosis to your second opinion appointment. Ideally, these should also include your scans on CDs and the actual tumor specimen on microscope slides. The doctors who have looked after you already should be able to provide these for you.


Adrenocortical carcinoma (ACC) is a rare cancer with an estimated 500 new cases annually is US.

  • The majority of ACC are sporadic (non-hereditary) with few recently identified genetic mutation syndromes.

Pheochromocytoma and paraganglioma are adrenal and extra-adrenal tumors, respectively, that secrets high amount of adrenaline.

  • Approximately more than 25% of pheochromocytomas/paragangiomas are hereditary, and about 20-25% of these tumors are malignant.

Functional Adrenal Tumors represent about 10-15% of all adrenal tumors.